Analysis of immune responses against H pylori in rabbits

World Journal of Gastroenterology

Volumn 13, Issue 4, 2007, Pages 600-606

  Islam, Khademul ^a   Khalil, Ibrahim ^a   Ahsan, Chowdhury Rafiqul ^a   Yasmin, Mahmuda ^a   Nessa, Jamalun ^a  

^a UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

H pylori; Immunogenicity; In house enzyme linked immunosorbent assay; Rabbit; Serum antibody kinetics; Whole cell antigen

Indexed keywords

BACTERIAL ANTIGEN; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGENICITY; NONHUMAN; RABBIT; WESTERN BLOTTING;

EID: 33846794522     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i4.600     Document Type: Article

References (33)

1. Van den Bulck K, Decostere A, Baele M, Marechal M, Ducatelle R, Haesebrouck F. Low frequency of Helicobacter species in the stomachs of experimental rabbits. Lab Anim 2006; 40: 282-287
2. Aucher P, Petit ML, Mannant PR, Pezennec L, Babin P, Fauchere JL. Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers. J Clin Microbiol 1998; 36: 931-936
3. Lepper PM, Moricke A, Vogt K, Bode G, Trautmannn M. Comparison of different criteria for interpretation of immunoglobulin G immunoblotting results for diagnosis of Helicobacter pylori infection. Clin Diagn Lab Immunol 2004; 11: 569-576
4. Barrow GI, Felthem RKA. Cown and Steel's Manual for the Identification of Medical Bacteria. 3rd editors. London: Cambrigde University Press, 2004: 121-130
5. Berstad AE, Brandtzaeg P, Stave R, Halstensen TS. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut 1997; 40: 196-203
6. Karttunen R, Karttunen T, Ekre HP, MacDonald TT. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995; 36:341-345
7. Mai UE, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 1991; 87: 894-900
8. Futagami S, Takahashi H, Norose Y, Kobayashi M. Systemic and local immune responses against Helicobacter pylori urease in patients with chronic gastritis: distinct IgA and IgG productive sites. Gut 1998; 43: 168-175
9. Mirbagheri SA, Hasibi M, Abouzari M, Rashidi A. Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. World J Gastroenterol 2006; 12: 4888-4891
10. Weltzin R, Guy B, Thomas WD Jr, Giannasca PJ, Monath TP. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Infect Immun 2000; 68: 2775-2782
11. Nystrom J, Raghavan S, Svennerholm AM. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect 2006; 8: 442-449
12. Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998; 188: 2277-2288
13. Monath TP, Lee CK, Ermak TH, Myers GA, Weltzin RA, Giannasca PJ, Thomas WD, Soman G, Bhagat H, Ackerman SA, Kleanthous HK. The Search for Vaccines Against Helicobacter pylori. Infect in Med 1998; 15: 534-546
14. Mayo K, Pretolani S, Gasbarrini G, Ghironzi G, Megraud F. Heterogeneity of immunoglobulin G response to Helicobacter pylori measured by the unweighted pair group method with averages. Clin Diagn Lab Immunol 1998; 5: 70-73
15. Nessa J, Chart H, Owen RJ, Drasar B. Human serum antibody response to Helicobacter pylori whole cell antigen in an institutionalized Bangladeshi population. J Appl Microbiol 2001; 90: 68-72
16. Axon AT. Treatment of Helicobacter pylori: future therapeutic and prophylactic perspectives. Gut 1998, 43 Suppl 1: S70-S73
17. Islam ABMMK, Yasmin K Ahasan R, Nessa J. Helicobacter pylori Infection in Bangladeshi Population: Serodiagnosis, Seroprevalence and Risk Factors. Dhaka Univ J Biol Sci 2005; 14(1):1-8
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
19. Chart H, Jenkins C, Smith HR, Rowe B. Serum antibodies to secreted proteins in patients infected with Escherichia coli O157 and other VTEC. Epidemiol Infect 1998; 120: 239-243
20. Rahman F, Islam ABMMK, Nessa J, Ahsan CR Yasmin M. Correlation in prevalence, risk factors and serological detection of Helicobacter pylori by different techniques. Bangladesh J Microbiol 2005; 22: 152-157
21. Towbin H, Gordon J. Immunoblotting and dot immunobinding - current status and outlook. J Immunol Methods 1984; 72: 313-340
22. Feldman RA, Eccersley AJ, Hardie JM. Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio. Br Med Bull 1998; 54: 39-53
23. Tam YH, Yeung CK, Lee KH. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study. Aliment Pharmacol Ther 2006; 24: 81-86
24. Kivi M, Tindberg Y. Helicobacter pylori occurrence and transmission: a family affair? Scand J Infect Dis 2006; 38: 407-417
25. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161: 626-633
26. Labigne A, de Reuse H. Determinants of Helicobacter pylori pathogenicity. Infect Agents Dis 1996; 5: 191-202
27. Appelmelk BJ, Simoons-Smit I, Negrini R, Moran AP, Aspinall GO, Forte JG, De Vries T, Quan H, Verboom T, Maaskant JJ, Ghiara P, Kuipers EJ, Bloemena E, Tadema TM, Townsend RR, Tyagarajan K, Crothers JM Jr, Monteiro MA, Savio A, De Graaff J. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoinummity. Infect Immun 1996; 64: 2031-2040
28. Ji KY, Hu FL. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases. World J Gastroenterol 2006; 12: 3789-3792
29. Haque M, Rahman KM, Khan AK, Hassan M, Miah MR, Qadri F, Akhter Q. Antigen profile of Helicobacter pylori strains isolated from peptic ulcer patients in Dhaka, Bangladesh. Bangladesh Med Res Counc Bull 1993; 19: 71-78
30. Radcliff FJ, Hazell SL, Kolesnikow T, Doidge C, Lee A. Catalase, a novel antigen for Helicobacter pylori vaccination. Infect Immun 1997; 65: 4668-4674
31. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995; 92: 6499-6503
32. Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, Herranz M, Saldinger PF, Corthesy-Theulaz I, Losonsky G, Nichols R, Simon J, Stolte M, Ackerman S, Monath TP, Blum AL. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 1999; 116: 804-812
33. Arora S, Czinn SJ. Vaccination as a method of preventing Helicobacter pylori-associated gastric cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1890-1891